Back to search

Article

Low-dose interleukin-2 for recurrent early pregnancy loss: a proof-of-concept study

2025-06-16

Abstract excerpt

<h4>Background</h4> Regulatory T cells (Tregs) are essential for maternal-fetal tolerance, and their deficiency has been implicated in immune-mediated pregnancy loss. Low-dose interleukin-2 (IL-2 LD ) selectively expands and activates Tregs and has shown efficacy in murine models of spontaneous immune-mediated miscarriage. This proof-of-concept study assessed the safety and efficacy of IL-2 LD in women with une...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
de89c576-4dcb-5c51-aeb5-d50863eeab9b
DOI
10.1101/2025.06.13.25328550
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low-dose interleukin-2 for recurrent early pregnancy loss: a proof-of-concept studyDOI 10.1101/2025.06.13.25328550
Select a neighboring publication to make it the new centre.